QA: AXIM BIOTECHNOLOGIES INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001514946_2023_AXIM_BIOTECHNOLOGIES_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001514946, AXIM BIOTECHNOLOGIES INC.

  xvar xval
0 AssetsCurrent 103,979
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 93,840
3 remainder_Assets 4,014,216
4 LiabilitiesCurrent 3,392,494
5 LiabilitiesNoncurrent 5,644,953
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,081,824
9 ResearchAndDevelopmentExpense 153,697
10 remainder_Expenses 426,126
11 remainder_Revenues 8,875
12 remainder_NetIncome 1,590,177
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 4,212,035
1 Liabilities 9,037,447
2 Expenses 4,661,647
3 Revenues 8,875
4 StockholdersEquity -4,825,412
5 NetIncome -3,062,595
6 ComprehensiveNetIncome -3,062,595
7 BaseVar 9,755,090
8 EconomicCapitalRatio -1.72

Edgar->Model Mapping

Feature Distribution

Change over Time